NCT01137084已完成不适用
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- patient and graft survival
研究概览
简要总结
The purpose of this study was to evaluate the safety and efficacy of a steroid-free immunosuppression protocol in Hepatocellular Carcinoma (HCC) patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All liver transplantation patients with hepatocellular carcinoma in our center between Jan 2005 and Dec 2009 were potentially eligible for enrollment
排除标准
- •the recipient pass away within 3 month following up liver transplantation
- •Inability to provide written informed consent prior to study entry
- •acute rejection are treated only with steroids
研究组 & 干预措施
a steroid immunosuppression protocol
Active Comparator
干预措施: solu medrol (Drug)
a steroid-free immunosuppression protocol
Active Comparator
without steroid
干预措施: a steroid-free immunosuppression protocol (Drug)
结局指标
主要结局
patient and graft survival
时间窗: Over 12-month after liver transplantation
patient and graft survival include surviral rate and recurrence-free survival rate
次要结局
- Postoperative complications(Over 12-month after liver transplantation)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Steroid Free Immunosuppression in Liver TransplantationLiver Transplant DisorderLiver CirrhosisNCT00296244Thomas Jefferson University40
已完成
4 期
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive RegimenKidney TransplantationRenal InsufficiencyNCT01560572University Medical Center Groningen305
已完成
4 期
Steroid free immunosuppression or calcineurin inhibitor minimization after Basiliximab induction therapy in kidney transplantation: Comparison with a standard quadruple immunosuppressive regimen.renal function10038430rejectionNL-OMON34397niversitair Medisch Centrum Groningen300
招募中
2 期
Expanding Liver Transplant Immunosuppression Minimization Via EverolimusLiver TransplantNCT06280950National Institute of Allergy and Infectious Diseases (NIAID)340
Unknown
不适用
Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) InfectionHCV RecurrenceLiver TransplantationDirect-acting Antiviral AgentsNCT01944527ANRS, Emerging Infectious Diseases699